Targeted vitamin D supplementation and major adverse cardiovascular events after myocardial infarction: the TARGET-D trial
Listen to this summary
The TARGET-D trial aimed to determine whether targeted vitamin D supplementation could reduce major adverse cardiovascular events in patients following a myocardial infarction. Despite high prevalence of vitamin D insufficiency among participants, the study found no significant difference in major cardiovascular outcomes between those receiving targeted vitamin D management and those receiving usual care. However, a notable reduction in myocardial infarction rates was observed in the vitamin D group compared to usual care.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More from European heart journal
View all →Sep 22, 2026 · European heart journal
Targeting trafficking defects in long QT syndrome type 2: a phase 2 clinical study with patient-specific cellular validation
Sep 21, 2026 · European heart journal
Intracranial haemorrhage following tenecteplase fibrinolysis for acute myocardial infarction
Sep 15, 2026 · European heart journal
Whole-grain consumption and cardiometabolic risk: a meta-analysis of randomized trials
Sep 10, 2026 · European heart journal
Exercise stress echocardiography for diagnosis of heart failure with preserved ejection fraction: a multicentre study
Sep 9, 2026 · European heart journal
Nighttime light exposure and cardiac structure and function
Sep 6, 2026 · European heart journal
Quality standards for preclinical research in cardio-oncology
More in Internal Medicine
View all →Sep 23, 2026 · JACC. Clinical electrophysiology
Programmed Ventricular Stimulation for Risk Stratification in Nonischemic Cardiomyopathy With Preserved or Mildly Reduced LVEF
Sep 23, 2026 · Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Five-Year Follow-Up of the Phase III ASCOT Trial of Adjuvant S-1 After Resection for Biliary Tract Cancer
Sep 23, 2026 · American journal of respiratory and critical care medicine
Biologic outcomes in severe asthma patients by smoking status: evidence from SHARP
Sep 23, 2026 · The New England journal of medicine
Effect of Screening with Multicancer Early-Detection Test on Late-Stage Cancer Diagnosis
Sep 23, 2026 · The New England journal of medicine
Phase 1 Study of Anito-cel, a d-Domain BCMA CAR T Cell for Refractory or Recurrent Myeloma
Sep 23, 2026 · American journal of respiratory and critical care medicine
Combined results of the TETON-1 and TETON-2 Trials of Inhaled Treprostinil for Idiopathic Pulmonary Fibrosis
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


